Avricore Health Inc.
AVCR.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -156.44% | 8.83% | 110.32% | 99.37% | 58.99% |
| Total Depreciation and Amortization | -18.45% | 5.54% | 25.60% | 45.73% | 77.04% |
| Total Amortization of Deferred Charges | 46.77% | 9.68% | 110.00% | 68.00% | 24.00% |
| Total Other Non-Cash Items | 109.25% | 82.78% | -38.55% | -16.93% | 56.67% |
| Change in Net Operating Assets | -116.60% | -146.09% | -177.36% | -136.96% | 1,753.85% |
| Cash from Operations | -18.91% | 49.97% | 131.26% | 277.90% | 696.94% |
| Capital Expenditure | 81.02% | 82.39% | 53.45% | 51.09% | 39.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.57% | 5.35% | -96.18% | -68.46% | -50.36% |
| Cash from Investing | 78.19% | 80.53% | 51.12% | 49.47% | 38.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 132.03% | 103.76% | -73.15% | -93.91% | -88.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,240.00% | 30.16% | -84.98% | -104.97% | -99.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 823.31% | 344.93% | 181.51% | 108.51% | 105.24% |